thiophenes has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuter, DJ | 1 |
| Ding, X; Gane, EJ; Hyland, RH; McHutchison, JG; Pang, PS; Stedman, CA; Subramanian, GM; Svarovskaia, E; Symonds, WT | 1 |
| Balsarotti, J; Briley, A; Dufner-Beattie, J; Noueiry, A; O'Guin, A; O'Guin, S; Olivo, PD; Rice, CM; Roth, R; Slomczynska, U; Starkey, G; Wang, B | 1 |
| Ardzinski, A; Bartels, DJ; Davis, A; Dorrian, J; Jiang, M; Kieffer, TL; Nelson, M; Nicolas, O; Rao, BG; Rijnbrand, R; Spanks, J; Sullivan, JC; Tigges, A; Zhang, EZ | 1 |
| Borgia, G; Buonomo, AR; Coppola, N; Gentile, I; Zappulo, E | 1 |
| Abbott, S; Akoth, E; Chavez, J; Emmanuel, B; Gross, C; Jolley, TA; Kattakuzhy, S; Kohli, A; Kottilil, S; Masur, H; McLaughlin, M; Meissner, EG; Mo, H; Nelson, A; Osinusi, A; Polis, MA; Price, A; Proschan, M; Seamon, C; Sidharthan, S; Silk, R; Sims, Z; Tang, L; Teferi, G; Wilson, E | 1 |
| Abramson, J; Allbaugh, RA; Alter, H; Amano, C; Amicarella, F; Ara, N; Armengou, L; Asano, N; Bai, SJ; Ben-Shlomo, G; Benoit, E; Bhatnagar, A; Bolli, R; Boulanger, F; Brohawn, P; Brouchkov, A; Buckner, JD; Bukh, J; Buysschaert, C; Carlson, M; Cesarini, C; Cheng, L; Chipinda, I; Cogle, CR; Cooke, JP; Costa, DB; Damotte, D; Das, S; Däster, S; De Chatterjee, A; De Leon, J; Delko, T; Devi, P; Dieu-Nosjean, MC; Droeser, RA; Duarte, T; Ebert, RF; Ecker, AH; Ellis, SG; Eppenberger-Castori, S; Farhoudi, A; Folch, E; Foster, DW; Frasson, D; Fujishima, F; Gangadharan, SP; Gao, W; Germain, C; Glanemann, M; Governa, V; Grant, MB; Hammond, SA; Han, CX; Haspel, RL; He, X; Heberer, M; Henry, TD; Hettick, J; Higgs, BW; Hirt, C; Huang, Y; Huberman, MS; Iezzi, G; Iijima, K; Imatani, A; Ishikawa, N; Izumi, H; Jeon, CO; Jessell, L; Joblin, C; Johnstone, BH; Jose-Cunilleras, E; Joseph, LJ; Jung, WY; Kanazawa, I; Kang, N; Kawaguchi, K; Kawai, K; Kent, MS; Kettelhack, C; Khurshid, SS; Kinney, KA; Kitajima, S; Knockaert, S; Koike, T; Kubo, M; Kuroda, E; Lai, D; Laschke, MW; Lassiter, T; Le, X; Lee, HJ; Lehmann, K; Li, D; Li, F; Li, J; Li, XX; Liu, J; Liu, Y; Liu, YY; Liu, Z; Ma, J; Maejima, R; Majid, A; Makielski, KM; Man, S; Mao, M; Margesin, R; Martincigh, BS; Maruyama, R; Mele, V; Mendez, TL; Menger, MD; Meuleman, P; Miyake, H; Morakinyo, MK; Morimoto, Y; Moussavian, MR; Moyé, L; Myojo, T; Nebiker, CA; Nejad, SA; Nestor, B; Noguchi, T; Oertli, D; Onaka, T; Orozco, A; Oyabu, T; Padovan, E; Pepine, CJ; Perin, EC; Pilleri, P; Prentoe, J; Qiu, P; Rangachari, D; Resende, M; Ríos, J; Robles-Martinez, L; Safarzadeh, MA; Sahraei, E; Salehi, MM; Sasaki, T; Sayre, SL; Schlachtenberger, G; Schutt, RC; Sconocchia, G; Sebastian, Y; Shimada, M; Shimosegawa, T; Siegel, JA; Siegel, PD; Simari, RD; Simoyi, RH; Song, YH; Soysal, SD; Spagnoli, GC; Strongin, R; Sugimoto, T; Tanaka, KI; Tang, XD; Tao, Y; Taylor, DA; Terracciano, L; Thiessen, CE; Tofflemire, KL; Tomonaga, T; Tornillo, L; Traverse, JH; Uno, K; Valge-Archer, V; Validire, P; VanderLaan, PA; Velázquez Moctezuma, R; Verhoye, L; Viu, J; von Heesen, M; von Holzen, U; Wagner, M; Wang, FY; Wang, R; Weixler, B; Whitley, RD; Willerson, JT; Windsor, LC; Wise, E; Wu, FZ; Wu, ZY; Yamamoto, K; Yano, S; Yao, Y; Yatera, K; Yin, Q; Yoshiura, Y; Zhang, DC; Zhang, L; Zhao, DX; Zhou, Y; Zhu, W; Zhu, X; Zierold, C; Zvolensky, MJ | 1 |
| Anderson, FH; Bédard, J; Boivin, I; Chauret, N; Cooper, C; Ghali, P; Lawitz, EJ; Lee, SS; Nicolas, O; Proulx, L; Rodriguez-Torres, M; Thibert, R | 1 |
| Cooper, C | 1 |
| Cho, SH; Choi, JY; Chon, CY; Han, JY; Jang, JJ; Jang, JW; Kim, SG; Kim, YM; Lee, DH; Lee, YS; Um, SH; Yu, E | 1 |
3 review(s) available for thiophenes and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag.
Topics: Anemia, Aplastic; Hepatitis C; Humans; Liver Diseases; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Thrombopoietin | 2022 |
GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection.
Topics: Antiviral Agents; Clinical Trials as Topic; DNA-Directed RNA Polymerases; Drug Resistance, Viral; Furans; Hepacivirus; Hepatitis C; Humans; Thiophenes; Viral Proteins | 2014 |
Viral response to specifically targeted antiviral therapy for hepatitis C and the implications for treatment success.
Topics: Animals; Antiviral Agents; Carboxylic Acids; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Protease Inhibitors; Remission Induction; Ribavirin; Thiophenes; Treatment Outcome | 2010 |
5 trial(s) available for thiophenes and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Enzyme Inhibitors; Fatigue; Female; Fluorenes; Furans; Genotype; Headache; Hepacivirus; Hepatitis C; Humans; Incidence; Male; Middle Aged; Nausea; Sofosbuvir; Thiophenes; Treatment Outcome; Uridine Monophosphate; Viral Nonstructural Proteins | 2014 |
Genotypic and phenotypic analyses of hepatitis C virus variants observed in clinical studies of VX-222, a nonnucleoside NS5B polymerase inhibitor.
Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Cyclohexanols; Drug Resistance, Viral; Genetic Variation; Genotype; Hepacivirus; Hepatitis C; Humans; Molecular Sequence Data; Mutation; Oligopeptides; Phenotype; Replicon; Thiophenes; Viral Nonstructural Proteins; Virus Replication | 2014 |
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial.
Topics: Antiviral Agents; Benzimidazoles; Drug Resistance, Viral; Drug Therapy, Combination; Female; Fluorenes; Furans; Genotype; Hepatitis C; Hepatitis C, Chronic; Humans; Male; Middle Aged; Quinolines; RNA, Viral; Sofosbuvir; Thiophenes; Treatment Outcome; Viral Load | 2015 |
Evaluation of VCH-759 monotherapy in hepatitis C infection.
Topics: Adult; Antiviral Agents; Carboxylic Acids; Double-Blind Method; Female; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Phenotype; Thiophenes; Viral Nonstructural Proteins | 2009 |
Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial.
Topics: Adult; Anticarcinogenic Agents; Biomarkers; Biopsy; Collagen; Double-Blind Method; Female; Hepatitis B; Hepatitis C; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Pyrazines; Thiones; Thiophenes; Transforming Growth Factor beta1 | 2011 |
2 other study(ies) available for thiophenes and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.
Topics: Adenosine; Antiviral Agents; Biological Assay; Cell Culture Techniques; Cell Line; Cell Survival; Cyclosporine; Furans; Genotype; Hepacivirus; Hepatitis C; High-Throughput Screening Assays; Humans; Luciferases, Renilla; Mutagenesis, Site-Directed; Oligopeptides; Pyridines; Replicon; Thiophenes; Viral Nonstructural Proteins; Virus Replication | 2014 |
Topics: Acid-Base Imbalance; Acidosis, Renal Tubular; Aged; Air Pollution, Indoor; Amino Acid Substitution; Animals; Animals, Newborn; Anti-Bacterial Agents; Antibodies, Neutralizing; Apoptosis; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Bone Marrow Transplantation; Carbonic Anhydrase Inhibitors; Castleman Disease; Cat Diseases; Cats; Cell Proliferation; Cell- and Tissue-Based Therapy; Chemical and Drug Induced Liver Injury; Chemotaxis, Leukocyte; Clinical Trials as Topic; Coated Materials, Biocompatible; Diagnosis, Differential; Disease Models, Animal; Environmental Monitoring; Female; Gas Chromatography-Mass Spectrometry; Genotype; Granuloma, Foreign-Body; Heart Failure; Hepacivirus; Hepatitis C; Horse Diseases; Horses; Housing; Humans; Hypercalcemia; Hypokalemia; Immunophenotyping; In Vitro Techniques; Liver; Liver Function Tests; Lymphocytes; Macrophages; Male; Medicine, Chinese Traditional; Metabolomics; Mice; Mice, Inbred C57BL; Middle Aged; Models, Animal; Mutation; Myocardial Ischemia; Neovascularization, Physiologic; Neutrophil Infiltration; Ocular Hypertension; Ophthalmic Solutions; Parathyroid Hormone; Particulate Matter; Polyethylene Terephthalates; Prednisolone; Prospective Studies; Prosthesis Design; Prosthesis-Related Infections; Rats; Rats, Wistar; Reactive Oxygen Species; Rifampin; Saponins; Sepsis; Skin; Stem Cells; Stroke Volume; Sulfonamides; Texas; Thiophenes; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Viral Hepatitis Vaccines; Viral Nonstructural Proteins; Viral Proteins; Vitamin D; Wound Healing | 2015 |